The Power of Truth® has been released for sale and assignment to a conservative pro-American news outlet, cable network, or other media outlet that wants to define and brand its operation as the bearer of the truth, and set itself above the competition.

In every news story the audience hears of censorship, speech, and the truth. The Power of Truth® has significant value to define an outlet, and expand its audience. A growing media outlet may decide to rebrand their operation The Power of Truth®. An established outlet may choose to make it the slogan distinguishing their operation from the competition. You want people to think of your outlet when they hear it, and think of the slogan when they see your company name. It is the thing which answers the consumer's questions: Why should I choose you? Why should I listen to you? Think:

  • What’s in your wallet -- Capital One
  • The most trusted name in news – CNN
  • Fair and balanced - Fox News
  • Where’s the beef -- Wendy’s
  • You’re in good hands -- Allstate
  • The ultimate driving machine -- BMW

The Power of Truth® is registered at the federal trademark level in all applicable trademark classes, and the sale and assignment includes the applicable domain names. The buyer will have both the trademark and the domains so that it will control its business landscape without downrange interference.

Contact: Truth@ThePowerOfTruth.com

Sunday, December 22, 2024
Sunday, December 22, 2024

An innovative stem cell-based treatment for Type 1 diabetes can meaningfully regulate blood glucose levels and reduce dependence on daily insulin injections, according to new clinical trial results. The therapy aims to replace the insulin-producing beta cells that people with Type 1 diabetes lack. Dubbed VC-02, the small medical implant contains millions of lab-grown pancreatic islet cells, including beta cells, that originate from a line of pluripotent stem cells.
Read more …Stem cell-based treatment controls blood sugar in people with Type 1 diabetes

Cell and gene therapies hold promise for treating various diseases, but technology to deliver targeted medicines to specific cells is lacking. Engineered cells produce multifunctional particles, designed to carry cargo and target specific cell types. In experiments, the particles successfully delivered gene editing cargo to T cells.
Read more …New platform solves key problems in targeted drug delivery

An international team of researchers has developed a method that combines advanced high-throughput microfluidics and gene editing technology to source new treatments that could potentially help people with autoimmune conditions and cancer. In validating the new technique, they discovered a molecule they believe could inhibit interferon gamma production in the gut which -- if proven in clinical trials -- could represent an ideal means to control inflammatory bowel disease (IBD).
Read more …Scientists devise new technique that can pinpoint the causes and treatments of autoimmune diseases

More Articles …

  1. Swine flu: UK detects first human case of new strain
  2. Dozens of US adolescents are dying from drug overdoses every month − an expert on substance use unpacks the grim numbers with 3 charts
  3. Why are bullies so mean? A youth psychology expert explains what's behind their harmful behavior
  4. Fresh pay offer could end NHS consultant strikes
  5. Hughie and Freddie: Fundraising cancer teen describes moment he got the all clear
  6. Hughie and Freddie: Fundraising teen on moment he got cancer all-clear
Page 949 of 1171